Development of carbapenem-based fluorogenic probes for the clinical screening of carbapenemase-producing bacteria
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Juhyeon | - |
dc.contributor.author | Kim, Yihoon | - |
dc.contributor.author | Abdelazem, Ahmed Z. | - |
dc.contributor.author | Kim, Hak Joong | - |
dc.contributor.author | Choo, Hyunah | - |
dc.contributor.author | Kim, Hoon Seok | - |
dc.contributor.author | Kim, Jung Ok | - |
dc.contributor.author | Park, Yeon-Joon | - |
dc.contributor.author | Min, Sun-Joon | - |
dc.date.accessioned | 2021-08-31T15:07:14Z | - |
dc.date.available | 2021-08-31T15:07:14Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 0045-2068 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/58516 | - |
dc.description.abstract | This report describes the synthesis of a library of fluorogenic carbapenemase substrates consisting of carbapenem derivatives, fluorescence dyes, and active cleavable linkers and their evaluation for specifically detecting carbapenemase-producing organisms (CPOs). We synthesized a series of compounds having three different types of linkers such as benzyl ether, carbamate, and amine using hydroxymethyl carbapenem 7a and hydroxyallyl carbapenem 7b as key intermediates. Probe 1b exhibited high stability and a prompt turn-on fluorescence signal upon hydrolysis by carbapenemases. In particular, the screening of clinical samples indicated that the probe 1b exhibited excellent selectivity to the CPOs over other beta-lactamases or non-carbapenemase producing bacteria, which may be of clinical use for the rapid and accurate detection of CPOs for timely diagnosis and treatment. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | BETA-LACTAMASE | - |
dc.subject | PSEUDOMONAS-AERUGINOSA | - |
dc.subject | ENTEROBACTERIACEAE | - |
dc.subject | RESISTANCE | - |
dc.subject | INHIBITORS | - |
dc.subject | PROPOSAL | - |
dc.subject | GENES | - |
dc.title | Development of carbapenem-based fluorogenic probes for the clinical screening of carbapenemase-producing bacteria | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Hak Joong | - |
dc.identifier.doi | 10.1016/j.bioorg.2019.103405 | - |
dc.identifier.scopusid | 2-s2.0-85076526923 | - |
dc.identifier.wosid | 000505596300061 | - |
dc.identifier.bibliographicCitation | BIOORGANIC CHEMISTRY, v.94 | - |
dc.relation.isPartOf | BIOORGANIC CHEMISTRY | - |
dc.citation.title | BIOORGANIC CHEMISTRY | - |
dc.citation.volume | 94 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | BETA-LACTAMASE | - |
dc.subject.keywordPlus | PSEUDOMONAS-AERUGINOSA | - |
dc.subject.keywordPlus | ENTEROBACTERIACEAE | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | INHIBITORS | - |
dc.subject.keywordPlus | PROPOSAL | - |
dc.subject.keywordPlus | GENES | - |
dc.subject.keywordAuthor | Carbapenems | - |
dc.subject.keywordAuthor | Carbapenemase-producing bacteria | - |
dc.subject.keywordAuthor | Linker | - |
dc.subject.keywordAuthor | Fluorescence | - |
dc.subject.keywordAuthor | Probes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.